A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

NCT06028230 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

70

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision. Not related to safety concern.

Conditions

Hidradenitis Suppurativa

Interventions

DRUG: SAR444656 (KT-474)
DRUG: Placebo

Sponsor

Sanofi

Collaborators

[object Object]